A) The balance of synaptic excitation and inhibition B) Only synaptic inhibition C) Only synaptic excitation D) The release of calcium ions
A) By enhancing inhibition or reducing excitation B) By destroying motor neurons C) By increasing excitation only D) By completely blocking all neuronal signals
A) By mimicking or enhancing endogenous inhibitory substances like GABA B) By blocking acetylcholine receptors C) By increasing dopamine production D) By depleting GABA levels in the brain
A) Only at the neuromuscular junction B) Cortex, brain stem, or spinal cord C) Exclusively in peripheral nerves D) Only in cardiac muscle tissue
A) Because they do not affect the nervous system at all B) Not every agent in this class has CNS activity, such as dantrolene C) Because they all act exclusively on peripheral muscles D) Because they only act on the spinal cord
A) As a centrally acting muscle relaxant B) As a purely peripheral agent C) As a non-steroidal anti-inflammatory drug D) As an antidepressant
A) As a directly acting agent B) As an anticonvulsant C) As a narcotic D) As a centrally acting agent
A) Spasmolytic B) Anesthetic C) Analgesic D) Antipyretic
A) Aspirin B) Paracetamol C) Ibuprofen D) Carisoprodol
A) Cyclobenzaprine B) Dantrolene C) Diazepam D) Baclofen
A) Fibromyalgia B) Type 2 diabetes C) Asthma D) Hypertension
A) Yes B) Only in severe cases C) No D) Only for elderly patients
A) Paracetamol or NSAIDs B) Antidepressants or anticonvulsants C) Opioids or steroids D) Antibiotics or antivirals
A) NSAIDs B) Barbiturates C) Antidepressants D) Opioids
A) Immunity to chronic pain B) Complete cure for fibromyalgia C) Reduction in blood pressure D) Benefit to treatment with NSAIDs
A) Extensive double-blind evidence B) Definitive clinical trial evidence C) No high-quality evidence D) Robust high-quality evidence
A) Yes, carisoprodol is superior to all others B) No drug has been shown to be better than another C) Yes, dantrolene is the least effective D) Yes, cyclobenzaprine is the most effective
A) Weight gain and hair loss B) Dizziness and drowsiness C) Insomnia and anxiety D) Hypertension and tachycardia
A) Extreme financial cost of manufacturing B) High risk of causing kidney failure C) Interference with digestive enzymes D) Possible abuse and interaction with other drugs
A) Speed of physical elimination B) Recommendation by the World Health Organization C) Brand name popularity and color D) Adverse-effect profile, tolerability, and cost
A) Neurological conditions such as spasticity B) Orthopedic conditions C) Gastrointestinal conditions D) Cardiovascular conditions
A) Cerebral palsy and multiple sclerosis B) Parkinson's disease and Alzheimer's disease C) ALS and muscular dystrophy D) Epilepsy and Huntington's disease
A) Cardiovascular effects B) CNS effects C) Gastrointestinal effects D) Renal effects
A) The CNS B) Skeletal muscle tissue C) The peripheral nervous system D) The neuromuscular junction
A) Lactic acid accumulation causes spasms B) Muscle fibers tear during stress C) Nerve compression directly triggers pain D) Pain induces spasm and spasm causes pain
A) Strong evidence proves this theory B) Considerable evidence contradicts this theory C) FDA studies have verified this theory D) Medical consensus fully accepts this theory
A) Neurologists B) Orthopedic surgeons C) Cardiologists D) Rheumatologists
A) To lower blood pressure B) To prevent morning stiffness C) To increase stage 4 sleep D) To block pain receptors
A) Patients heal broken bones faster B) Patients experience immediate weight loss C) Patients feel more refreshed in the morning D) Patients build muscle mass overnight
A) Baclofen B) Tizanidine C) Dantrolene D) Metaxalone
A) Baclofen and dantrolene B) Metaxalone and methocarbamol C) Diazepam and carisoprodol D) Cyclobenzaprine and tizanidine
A) Those with lactose intolerance B) Those with a history of drug or alcohol addiction C) Those with seasonal allergies D) Those with a history of high blood pressure
A) Acetylcholine B) Serotonin C) GABA D) Dopamine
A) Excitation B) Inhibition C) Polarization D) Metabolism
A) 1973 B) 2000 C) 1985 D) 1950
A) Low back pain B) Tension headaches C) Fibromyalgia D) Hypertension
A) Beta-blockers B) Diuretics C) Spasmolytics D) Anticoagulants
A) Enhanced neurological reflexes. B) Increased muscle tone and strength. C) Permanent muscle relaxation. D) Temporary paralysis.
A) Belladonna. B) Hemlock. C) Strychnine. D) Curare.
A) Cocaine. B) Atropine. C) Tubocurarine. D) Morphine.
A) Serotonin. B) Acetylcholine. C) Dopamine. D) Adrenaline.
A) 1943. B) 1977. C) 1962. D) 1959.
A) 1959. B) 1977. C) 1962. D) 1943.
A) August 1959. B) August 1962. C) August 1943. D) August 1977.
A) August 1985. B) August 1962. C) August 1977. D) August 1959.
A) Barbiturate. B) Benzodiazepine. C) Anticholinergic. D) Opioid.
A) Clonidine. B) Diazepam. C) Atropine. D) Baclofen.
A) Chlorzoxazone. B) Metaxalone. C) Dantrolene. D) Tetrazepam.
A) Penicillin. B) Methocarbamol. C) Aspirin. D) Ibuprofen.
A) Lisinopril. B) Paracetamol. C) Omeprazole. D) Mephenoxalone.
A) Cyclobenzaprine. B) Tizanidine. C) Metaxalone. D) Meprobamate.
A) Anticholinergics. B) Methaqualone. C) Benzodiazepines. D) Clonidine relatives.
A) Yes. B) Only when combined with antibiotics. C) Only in veterinary medicine. D) No.
A) Dantrolene. B) Equagesic. C) Metaxalone. D) Baclofen.
A) Morphine patches. B) Tramadol tablets. C) Fentanyl preparations. D) Codeine syrups.
A) Whole opium products. B) Topical opium creams. C) Synthetic opium isolates. D) Homeopathic opium dilutions.
A) Ketobemidone. B) Oxycodone. C) Methadone. D) Hydrocodone.
A) Calcium ions B) Sodium ions C) Potassium ions D) Chloride ions
A) One B) Two C) Three D) Four
A) Ca2+ B) Mg2+ C) Na+ D) K+
A) A flexible sodium channel B) A rigid carbon ring system C) A calcium ion bond D) An acetylcholine esterase bridge
A) Central nervous system B) Muscle membrane C) Skin epithelium D) Motor end plate
A) Endocytosis B) Reverse polarization C) Active transport D) Diffusion
A) Enzyme B) Agonist C) Antagonist D) Inhibitor
A) Permanent blindness B) Kidney failure C) Bone mineralization D) Dependence
A) GABAA receptors B) GABAB receptors C) Ryanodine receptors D) Alpha-2 adrenergic receptors
A) Increased potassium ion conductance B) Decreased chloride ion transport C) Increased sodium ion influx D) Decreased potassium ion conductance
A) It depresses excitatory feedback from muscles B) It stops all electrical activity in the muscle fiber C) It increases excitatory feedback from muscles D) It enhances calcium release from the sarcoplasmic reticulum
A) Extracellular fluid B) Sarcoplasmic reticulum C) Cell nucleus D) Mitochondria
A) Glycine receptor channel B) Alpha-2 adrenergic receptor channel C) Ryanodine receptor channel D) GABAA receptor channel
A) They are stimulated to contract faster B) They are depressed only slightly C) They are completely paralyzed D) They are unaffected
A) Insomnia B) Hyperactivity C) Sedation D) Muscle spasms
A) Dry mouth B) Hair loss C) Increased appetite D) Weight gain
A) Improved hearing B) Rapid weight loss C) High energy D) Blurred vision
A) Muscle growth B) Extreme hunger C) Hallucinations D) Insomnia
A) Slight dry mouth B) Temporary fatigue C) Severe allergic reactions D) Mild drowsiness |